Pharma Insider Sells 4,772 Shares as 2025 Revenue Hits $883M
A high-stakes earnings year and a single insider trade create a nuanced picture for ANI Pharmaceuticals. This guide b...
Best Dividend ETFs highlights top options for generating income and potential appreciation. This intro guides you through evaluating yields and costs.
13,171 articlesA high-stakes earnings year and a single insider trade create a nuanced picture for ANI Pharmaceuticals. This guide b...
A durable capex cycle is forming around upgrading the power grid to handle AI, EV charging, and reshoring needs. Anal...
Titan America (TTAM) is shaping investor expectations in 2026 as Q1 results roll in. This deep dive translates earnin...
A short clip can rewrite a night’s narrative. That viral video Rihanna may spark questions about wealth, stamina, and...
The New York Fed reports 9.7% of student loan balances are 90+ days delinquent in Q1 2026, signaling rising retiremen...
A new NRMLA webinar explores how caregiving and intergenerational concerns influence reverse mortgage choices, offeri...
A focused look at Toast's Q1 2026 results and what they imply for toast (tost) 2026 earnings. Expect discussion of re...
Planning for retirement often hinges on one big question: can you live portfolio earnings alone without worry? This g...
Huntington & Ellis launches Smart by h&e, an in-house AI assistant designed to streamline deals, draft communications...
A hedge fund manager publicly admits that his temperament blocks Buffett-style value investing. The admission highlig...
Losing a partner upends more than your personal life—it can reshape your income too. This guide walks you through the...
Frontier is expanding capacity in key markets after Spirit exits, betting on demand and scale. The move highlights a ...